Table 1.

Main clinical characteristics at diagnosis of the 71 patients with EGPA, according to ANCA status

ManifestationsANCA+ (n=37)ANCA- (n=34)P
Fever30 (81.1)25 (73.5)0.57
Myalgia22 (59.5)10 (29.4) 0.02
ENT33 (89.2)30 (88.2)1.00
Lung24 (64.9)19 (55.9)0.47
Cutaneous24 (64.9)15 (44.1)0.10
Peripheral neuropathy30 (81.1)21 (61.8)0.11
Mononeuritis multiplex17 (45.9)6 (17.6) 0.01
Cardiovascular13 (35.1)10 (29.4)0.62
Gastrointestinal4 (10.8)4 (11.8)1.00
Renal11 (29.7)5 (14.7)0.16
BVAS at diagnosis, mean ± SD16.86±6.4412.62±5.52 <0.01
VDI at the end of the follow-up2.43±1.571.76±1.16 <0.01